Downregulation of Collagen COL4A6 Is Associated with Prostate Cancer Progression and Metastasis.

Jian-Bin Ma,Ji-Yu Bai,Hai-Bao Zhang,Lijiang Gu,Dalin He,Peng Guo
DOI: https://doi.org/10.1089/gtmb.2020.0009
IF: 1.736
2020-01-01
Genetic Testing and Molecular Biomarkers
Abstract:Aims:To determine the association between collagen type IV alpha 6 (COL4A6) expression and prostate cancer invasion and metastasis. Methods:We analyzed three Gene Expression Omnibus (GEO) datasets through the GEO2R online tool to obtain the set of differentially expressed genes (DEGs) between malignant and nonmalignant prostate tissues, and further analyzed theCOL4A6gene's expression in databases. Western blot assays, real-time quantitative polymerase chain reaction analysis, and immunofluorescence staining were used to detectCOL4A6gene expression. Wound healing assays and cell invasion transwell assays were performed to measure cell invasion and siRNA was used to knock downCOL4A6gene expression. Results:Through the use of bioinformatic tools we showed that theCOL4A6gene is one of the highly downregulated genes in prostate cancer; additionally, hypermethylation of theCOL4A6promoter in prostate cancer is correlated with lower expression levels. We also showed that downregulation ofCOL4A6, which activates the p-FAK/MMP-9 signaling pathway in prostate cancer cells, is associated with prostate cancer cell metastasis based on data retrieved from The Cancer Genome Atlas (TCGA) and GEO databases. Finally, we found that the COL4A6 protein is localized extracellularly and its expression is positively correlated with disease-free survival of prostate cancer patients. Conclusion:Our results indicate that downregulation of COL4A6 may promote prostate cancer progression and invasion. Additionally,COL4A6and its promoter methylation status could be valuable markers for prostate cancer prognoses.
What problem does this paper attempt to address?